ARCHIVES

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

This article is from The Cancer Letter archive.

Vol. 16 No. 01 | January 5, 1990

Download PDF Visit The Full Archive

Related Articles

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

Velcade Addition Can Improve Graft-Versus-Host Outcomes

December 27, 2013

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named

June 15, 1990